Eric Feldman
Keine laufenden Positionen mehr
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Peter van Vlasselaer | M | 64 |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | 5 Jahre |
peter vlasselaer | M | - |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | 6 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Franklin Berger | M | 74 | 10 Jahre | |
John McLaughlin | M | 72 | 9 Jahre | |
John Orwin | M | 59 | 9 Jahre | |
Kirk D. Schumacher | M | - | 11 Jahre | |
Jean Liu | F | 55 | 9 Jahre | |
Christopher Boerner | M | 53 | 5 Jahre | |
Dennis Benjamin | M | - | 3 Jahre | |
Naomi Hunder | M | 54 | 7 Jahre | |
Leslie Aberman | F | - | 8 Jahre | |
Stanford Peng | M | 53 | 1 Jahre | |
Brandi Robinson | F | - | 2 Jahre | |
David Fontana | M | - | - | |
Robert Lechleider | M | - | 4 Jahre | |
Elizabeth Bekiroglu | F | 54 | 5 Jahre | |
Eric Sievers | M | 60 | 9 Jahre | |
Florian Fischer | M | 56 |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | - |
Tina Albertson | M | 51 | 5 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 19 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Eric Feldman
- Persönliches Netzwerk